BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24973797)

  • 21. Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.
    Lu CL; Chuang YC; Chang HC; Chen YC; Wang JT; Chang SC
    J Antimicrob Chemother; 2012 Sep; 67(9):2243-9. PubMed ID: 22618861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.
    Douglas AP; Marshall C; Baines SL; Ritchie D; Szer J; Madigan V; Chan HT; Ballard SA; Howden BP; Buising K; Slavin MA
    J Med Microbiol; 2019 Mar; 68(3):303-308. PubMed ID: 30663951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
    Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
    Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice.
    Miyazaki S; Fujikawa T; Kobayashi I; Matsumoto T; Tateda K; Yamaguchi K
    J Med Microbiol; 2001 Aug; 50(8):695-701. PubMed ID: 11478673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phenotypic and genotypic traits of vancomycin-resistant enterococci in a public hospital: the first vanB-positive Enterococcus faecium isolates].
    Coşkun FA; Mumcuoğlu I; Aksu N; Karahan ZC; Us E; Tekeli FA; Baran I; Kanyılmaz D; Kurşun S
    Mikrobiyol Bul; 2012 Apr; 46(2):276-82. PubMed ID: 22639316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2019.
    Coombs GW; Daley DA; Mowlaboccus S; Pang S;
    Commun Dis Intell (2018); 2020 Sep; 44():. PubMed ID: 32988338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
    Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
    Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers : A retrospective case control study.
    Kaya A; Kaya SY; Balkan II; Bayramlar OF; Mete B; Saltoglu N; Aygün G; Tabak ÖF
    Wien Klin Wochenschr; 2021 May; 133(9-10):478-483. PubMed ID: 32910333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary.
    Franyó D; Kocsi B; Bukta EE; Szabó J; Dombrádi Z
    Folia Microbiol (Praha); 2020 Jun; 65(3):483-490. PubMed ID: 31686360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci.
    da Silva NS; Muniz VD; Estofolete CF; Furtado GH; Rubio FG
    Am J Infect Control; 2014 Apr; 42(4):389-92. PubMed ID: 24679566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First detection of vanB phenotype-vanA genotype vancomycin-resistant enterococci in Egypt.
    Khairy RM; Mahmoud MS; Esmail MAM; Gamil AN
    J Infect Dev Ctries; 2019 Sep; 13(9):837-842. PubMed ID: 32074094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates.
    Bell JM; Paton JC; Turnidge J
    J Clin Microbiol; 1998 Aug; 36(8):2187-90. PubMed ID: 9665988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of virulence determinants, aminoglycoside and vancomycin resistance in enterococci isolated from hospitalized patients in Northwest Iran.
    Haghi F; Lohrasbi V; Zeighami H
    BMC Infect Dis; 2019 Aug; 19(1):744. PubMed ID: 31455296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
    Zaas AK; Song X; Tucker P; Perl TM
    Clin Infect Dis; 2002 Nov; 35(10):1139-46. PubMed ID: 12410472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of discontinuing isolation in a private room for patients infected or colonized with vancomycin-resistant enterococci (VRE) on the incidence of healthcare-associated VRE bacteraemia in a hospital with a predominantly shared-room setting.
    Chang E; Im D; Lee HY; Lee M; Lee CM; Kang CK; Park WB; Kim NJ; Choe PG; Oh M
    J Hosp Infect; 2023 Feb; 132():1-7. PubMed ID: 36473555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies.
    Furtado GH; Mendes RE; Pignatari AC; Wey SB; Medeiros EA
    Am J Infect Control; 2006 Sep; 34(7):447-51. PubMed ID: 16945692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
    Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
    Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.
    Johnson PD; Ballard SA; Grabsch EA; Stinear TP; Seemann T; Young HL; Grayson ML; Howden BP
    J Infect Dis; 2010 Oct; 202(8):1278-86. PubMed ID: 20812846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada.
    Johnstone J; Chen C; Rosella L; Adomako K; Policarpio ME; Lam F; Prematunge C; Garber G;
    Am J Infect Control; 2018 Nov; 46(11):1266-1271. PubMed ID: 29903421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital.
    MacIntyre CR; Empson M; Boardman C; Sindhusake D; Lokan J; Brown GV
    Infect Control Hosp Epidemiol; 2001 Oct; 22(10):624-9. PubMed ID: 11776348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.